Research team for Abiomed's battery heart expands
This article was originally published in Clinica
Abiomed is preparing for clinical trials of its battery-powered heart after finalising several collaborative agreements with five US medical centres, as part of its drive to expand its project and research team. The company is building a fully-implantable heart as a permanent replacement for a diseased organ.
You may also be interested in...
Oncology Center of Excellence is reviewing a research report on fluorouracil, and will next look to update cisplatin's label, but eventually must convince the reference product sponsor to submit the changes.
US FDA’s ‘Project Renewal’ requires lots of work and flexibility, Oncology Center of Excellence acknowledges. Side-benefit may be getting outside physicians to appreciate the value of drug labeling.
The pharmaceutical industry would lose bid to eliminate PUPSIT but win relaxed WFI in proposed EU GMP Annex I revision.